Publications
59
Citations
2,111
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2007
Alex C. Kim's research centers on cancers involving the peritoneum (the lining of the abdominal cavity), particularly colorectal and appendiceal cancers that have spread to this region. Work spans clinical topics like surgical treatment and timing of therapy, molecular profiling of tumors using blood-based DNA tests, and drug resistance mechanisms, alongside some collaborative work on imaging agents and healthcare workforce issues. The output includes clinical trial results, review articles, and case reports, suggesting involvement in both laboratory-adjacent research and direct patient care studies.
Publication output was minimal or absent through the late 2010s but has grown substantially since 2022, reaching a peak of activity in 2023-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Treatment Delays in Early Age–Onset Colorectal Cancer
JAMA Oncology · 2026
- Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts
Cancer Cell · 2026
- Comprehensive analysis of PIK3CA mutations in advanced colorectal cancer using circulating tumor DNA profiling
npj Precision Oncology · 2025
- SRC at the crossroads of KRAS inhibitor resistance: Mechanisms and therapeutic opportunities
Cancer Letters · 2025
- Molecular and Genetic Markers of Peritoneal Metastasis
Surgical Oncology Clinics of North America · 2025
- Peritoneal Surface Malignancy
Surgical Oncology Clinics of North America · 2025
- Peritoneal Surface Malignancy
Surgical Oncology Clinics of North America · 2025
- How does a GPT perform in Forecasting Severe Respiratory Disease Hospitalizations?
2025
- New Focal Epileptogenesis Following Electroconvulsive Therapy: A Case Report and Literature Review
Military Medicine · 2025
- The effects of perceived workplace safety on U.S. healthcare workers’ mental health symptomatology
Journal of Workplace Behavioral Health · 2025
- Time to treatment initiation (TTI) in patients with colorectal cancer and liver metastases.
Journal of Clinical Oncology · 2025
- Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study
Annals of Surgical Oncology · 2024
- Rapid Affinity and Microsomal Stability Ranking of Crude Mixture Libraries of Histone Deacetylase Inhibitors
ACS Medicinal Chemistry Letters · 2024
- Preanalytical protocol for fresh solid tumor biospecimens
Research Square · 2024
- ASO Visual Abstract: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent—Final Results from a Phase 2 Study
Annals of Surgical Oncology · 2024
- Annals of Surgical Oncology×4
- Journal of Gastrointestinal Surgery×3
- Surgical Oncology Clinics of North America×3
- Hepatology×2
- Cancer Cell×2
- Alex Kim
Medicine · The Ohio State University
- Jennifer Vazzano
Medicine · The Ohio State University
- Jordan M. Cloyd
Medicine · The Ohio State University
- Aayush Vishwanath
Medicine · The Ohio State University
- Larry J. Copeland
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile